Usher syndromes-gene therapies (IVERIC bio)

N/A

Report date: 2024/01/11 15:38:55

Base Information

Drug NameUsher syndromes-gene therapies (IVERIC bio)
Drug Alias Namemini-USH2A (Iveric)Minigene Programmes (IVERIC bio)mini-USH2Amini-USH-2-Amini-USH-2A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transferenceUsherin modulators
TargetsUsherin
Therapy Area/IndicationsUsher Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Massachusetts Medical School
China Registration ClassN/A

Develop Information

Active CompaniesIveric Bio Inc
Inactive CompaniesN/A
Active IndicationsUsher Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A